Dr. Jason E. Schend, DO

Dr. Schend practices at Sanford Allergy and Immunology Clinic - HOPD in Sioux Falls, South Dakota.

Dr. Schend's NPI, 1861833774, was assigned on July 9, 2013. Dr. Schend graduated from Pacific NW Un of HS, Col of Osteopathic Medicine in 2015. Dr. Schend holds South Dakota license 14400.

Dr. Schend's primary practice is Sanford Allergy and Immunology Clinic - HOPD, at 1321 W 22nd St, Sioux Falls, SD 57105.

Dr. Schend's primary practice is Sanford Allergy and Immunology Clinic - HOPD in Sioux Falls, South Dakota. Dr. Schend is also affiliated with Sanford USD Medical Center. The medical group on file is Edith Sanford Breast Center Sioux Falls. Dmand AI also links Dr. Schend to 1 more dialysis center, named with a free account. Dr. Schend's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schend practices, 3 sites in all. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Schend's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dr. Schend is licensed in South Dakota.

CMS data shows 632 Medicare services from Dr. Schend across 5 procedure codes in 2024, for 52 Medicare patients. Medicare paid $7,302 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 52 Medicare patients who saw Dr. Schend in 2024. The largest group is 65 to 74, with 28 patients. 69% of them have high cholesterol, and 58% have high blood pressure. Their average risk score is 1.20, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Schend's median patient age at 45, with 57% women.

In 2024, Dr. Schend wrote 278 Medicare Part D claims for 47 patients. 69% of them were for generic drugs. CMS names the drug for 124 of them, across 7 drugs with 11 or more claims each, at $12,205 in total drug cost. In 2023, CMS named 207 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Schend for performance year 2024, reported as part of a group. Dr. Schend accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 9 papers to Dr. Schend, published from 2017 to 2023. 2020 was the busiest year, with 3. The most frequent topics are Common Variable Immunodeficiency, Diagnosis, Differential and Osteopathic Medicine. Dr. Schend has published most often in Allergy Rhinol (Providence). Dr. Schend's most frequent co-authors are Robert W. Hostoffer, DO, Neha Sanan, DO and John Andrew Johnson, DO.

CMS Open Payments shows 251 general payments to Dr. Schend from 31 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 61% of the total. AstraZeneca Pharmaceuticals LP paid the most, $9,202.

Dr. Schend graduated from Pacific NW Un of HS, Col of Osteopathic Medicine in 2015.